As PSA tests fall, metastatic prostate cancer rises

EFFORTS to rein in PSA testing have coincided with a marked rise in metastatic prostate cancer in the US, new data shows.

There's no equivalent data in Australia, but urologists are now concerned that a similar pattern could emerge closer to home.

PSA testing in the US declined from 2008, after the Preventive Services Task Force issued a caution about the risks of false positives and resultant overtreatment.

To clarify the impact of screening changes on prostate cancer, researchers analysed the national US